| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 53.842 | 68.031 | 93.386 |
| Total Income - EUR | - | - | - | - | - | - | - | 53.842 | 68.035 | 93.386 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 24.929 | 43.169 | 44.667 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 28.913 | 24.866 | 48.720 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 28.366 | 24.185 | 46.254 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Slavu Anghel-Paul Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 73.806 | 58.271 | 44.672 |
| Current Assets | - | - | - | - | - | - | - | 24.325 | 19.855 | 49.474 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 23.930 | 5.897 | 35.060 |
| Cash | - | - | - | - | - | - | - | 395 | 13.958 | 14.414 |
| Shareholders Funds | - | - | - | - | - | - | - | 28.407 | 24.880 | 48.051 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 70.334 | 53.724 | 47.002 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Slavu Anghel-Paul Med S.r.l.